Pharmaceutical Analytical Testing Outsourcing Services Market, By Bioanalytical Testing (Clinical and Non-Clinical), By Method Development & Validation (Extractable & Leachable, Impurity Method, Technical Consulting, and Others), By Stability Testing (Drug Substance, Stability Indicating Method Validation, Accelerated Stability, Photostability, and Others), and By Region - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

DFS020133  | 
: Life Sciences & Healthcare  | 
Mar-2024  | 
Upcoming  | 
Pages: NA  | 
Tables: NA  | 
Figures: NA
We’ve been tracking the direct impact of COVID-19 on this market, as well as the indirect impact from other industries. The report will incorporate these insights.

Pharmaceutical Analytical Testing Outsourcing Services Market accounted 6.6 USD billion in 2020 and is expected to reach 15.3 USD billion by 2030 growing with a CAGR of 8.7% during the forecast period. Analytical testing services help pharmaceutical companies in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars & biologics, and improving productivity. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This has subsequently lead to an increase in the requirement of outsourcing pharmaceutical analytical testing services. One of the main reasons for outsourcing analytical testing services is to get benefited from skilled and experienced professionals, as well as to access expensive analytical equipment that is not available in-house. Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have played an important role in the discovery and development of drugs. Increasing focus on customized services and technological advancements is shortening the product lifecycle, which has resulted in the rapid development of new products. Outsourcing services are the most favored option for many pharmaceutical companies to increase access therapeutic expertise, operational efficiency, and benefit from on-demand services.

Market Segmentation:

The global pharmaceutical analytical testing outsourcing services market is segmented by bioanalytical testing type into clinical and non-clinical. By the method of development & validation, the market is categorized into extractable & leachable, impurity methods, technical consulting, and others. By stability testing the market is categorized into drug substance, stability-indicating method validation, accelerated stability, photostability, and others. The market is divided into other testing services also which comprise environmental monitoring, raw material testing, batch release, microbial testing, and physical characterization of materials. By geography, pharmaceutical analytical testing outsourcing services market is divided into North America, Asia Pacific, Europe, and the RoW. 

Market Dynamics and Factors:

Increasing pipelines for biologic drugs, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth. Technology transfer and services extension from one region to another, which requires Government approval may slow down the growth of the pharmaceutical analytical testing outsourcing services market. The intensifying pressure on pharmaceutical and biopharmaceutical organizations in rejuvenating their drug pipelines across R&D cost-cutting measures will boost the demand for analytical testing outsourcing services.

Geographic Analysis:

North America has dominated the global pharmaceutical analytical testing outsourcing services market with a share of 54.2% during 2019.  North America is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals and the reason why outsourcing of clinical bioanalytical testing services has emerged as the largest segment in this region, with a share of around 79%. The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices. Asia Pacific is projected to be the fastest-growing market as an opportunity for the existing key players of developed countries, who are focusing on expanding their presence in this region. Outsourcing services in this region are generally supported by delivery centers in Manila, China, and India.

Competitive Scenario:

Some of the key players operating in the pharmaceutical analytical testing outsourcing services market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc. 

Pharmaceutical Analytical Testing Outsourcing Services Market Report Scope

Report Attribute

Details

Analysis Period

2020–2030

Base Year

2021

Forecast Period

2022–2030

Market Size Estimation

Billion (USD)

Growth Rate (CAGR%)

8.7 %

Market Segmentation:

By Bioanalytical Testing (Clinical and Non-Clinical), By Method Development & Validation (Extractable & Leachable, Impurity Method, Technical Consulting, and Others), By Stability Testing (Drug Substance, Stability Indicating Method Validation, Accelerated Stability, Photostability, and Others)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa)

Key Companies Profiled

Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc. 


TOC REQUEST


KEY MARKET SEGMENTS:

  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Bioanalytical Testing
    • Clinical
    • Non-Clinical
  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Method Development & Validation 
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability
    • Photostability
    • Others
  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • France
      • Germany
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia Pacific
    • ROW
      • Latin America
      • Middle East
      • Africa

KEY PLAYERS
o    Toxikon, Inc.
o    Intertek Group PLC
o    SGS SA
o    Eurofins Scientific; Boston Analytical
o    Pace Analytical Services, LLC
o    West Pharmaceutical Services, Inc.
o    Intertek Group Plc
o    Pharmaceutical Product Development, LLC
o    WuXi AppTec, Inc.
o    Charles River Laboratories International, Inc.


 
©2024 Decision Foresight. All Rights Reserved.